These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11036030)

  • 1. Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants.
    Adrian PV; Mendrick C; Loebenberg D; McNicholas P; Shaw KJ; Klugman KP; Hare RS; Black TA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3101-6. PubMed ID: 11036030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action.
    Adrian PV; Zhao W; Black TA; Shaw KJ; Hare RS; Klugman KP
    Antimicrob Agents Chemother; 2000 Mar; 44(3):732-8. PubMed ID: 10681347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit.
    Belova L; Tenson T; Xiong L; McNicholas PM; Mankin AS
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3726-31. PubMed ID: 11259679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin.
    McNicholas PM; Mann PA; Najarian DJ; Miesel L; Hare RS; Black TA
    Antimicrob Agents Chemother; 2001 Jan; 45(1):79-83. PubMed ID: 11120948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
    Wolter N; Smith AM; Farrell DJ; Klugman KP
    Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.
    Takaya A; Sato Y; Shoji T; Yamamoto T
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3789-96. PubMed ID: 23716046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
    Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.
    Depardieu F; Courvalin P
    Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.
    Mann PA; Xiong L; Mankin AS; Chau AS; Mendrick CA; Najarian DJ; Cramer CA; Loebenberg D; Coates E; Murgolo NJ; Aarestrup FM; Goering RV; Black TA; Hare RS; McNicholas PM
    Mol Microbiol; 2001 Sep; 41(6):1349-56. PubMed ID: 11580839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in ribosomal protein L16 and in 23S rRNA in Enterococcus strains for which evernimicin MICs differ.
    Zarazaga M; Tenorio C; Del Campo R; Ruiz-Larrea F; Torres C
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3657-9. PubMed ID: 12384386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.
    Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS
    J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.
    Taylor DE; Ge Z; Purych D; Lo T; Hiratsuka K
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2621-8. PubMed ID: 9420030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.
    Billal DS; Feng J; Leprohon P; Légaré D; Ouellette M
    BMC Genomics; 2011 Oct; 12():512. PubMed ID: 22004526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
    Lucier TS; Heitzman K; Liu SK; Hu PC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2770-3. PubMed ID: 8593017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations.
    Sander P; Belova L; Kidan YG; Pfister P; Mankin AS; Böttger EC
    Mol Microbiol; 2002 Dec; 46(5):1295-304. PubMed ID: 12453216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
    Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.